Prestige Consumer Healthcare (PBH) EPS (Diluted) Growth (5y) (2015 - 2025)
Prestige Consumer Healthcare (PBH) EPS (Diluted) Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.37 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.74% |
| Sep 30, 2025 | -0.54% |
| Jun 30, 2025 | 2.06% |
| Mar 31, 2025 | 6.68% |
| Dec 31, 2024 | 10.27% |
| Sep 30, 2024 | 10.69% |
| Jun 30, 2024 | 8.41% |
| Mar 31, 2024 | 18.82% |
| Dec 31, 2023 | 7.68% |
| Sep 30, 2023 | 12.58% |
| Jun 30, 2023 | 10.27% |
| Mar 31, 2023 | -45.42% |
| Dec 31, 2022 | -29.35% |
| Sep 30, 2022 | 12.10% |
| Jun 30, 2022 | 11.55% |
| Mar 31, 2022 | 37.58% |
| Dec 31, 2021 | 10.70% |
| Sep 30, 2021 | 8.14% |
| Jun 30, 2021 | 66.76% |
| Mar 31, 2021 | 21.76% |